MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, NXTC has $37,977K in assets. $11,261K in debts. $15,167K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
460.62%
Quick Ratio
460.62%
Cash Ratio
220.10%
Debt to Asset Ratio
29.65%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities
    • Property and equipment, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Lease liabilities, long term
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
15,167 25,982 7,324 4,892
Marketable securities
14,576 15,836 21,786 30,416
Prepaid expenses and other current assets
1,998 1,929 3,530 4,707
Total current assets
31,741 43,747 32,640 40,015
Property and equipment, net
2,990 3,273 3,638 4,171
Right of use assets
2,399 2,617 2,785 2,948
Other assets
847 546 550 555
Total assets
37,977 50,183 39,613 47,689
Accounts payable
3,070 2,011 2,391 2,544
Accrued liabilities and other liabilities
3,821 8,555 8,604 8,237
Total current liabilities
6,891 10,566 10,995 10,781
Lease liabilities, long term
3,879 4,148 4,411 4,666
Other long-term liabilities
491 526 561 596
Total liabilities
11,261 15,240 15,967 16,043
Common stock, par value of 0.001 per share 100,000,000 shares authorized at march 31, 2026 and december 31, 2025 3,607,555 and 3,505,621 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
4 4 3 2
Additional paid-in capital
472,490 470,898 450,170 447,571
Accumulated other comprehensive (loss) income
-2 21 17 -7
Accumulated deficit
-445,776 -435,980 -426,544 -417,920
Total stockholders' equity
26,716 34,943 23,646 29,646
Common stock, par value of 0.001 per share 100,000,000 shares authorized at june 30, 2025 and december 31, 2024 338,636 and 0 shares issued and outstanding at june 30, 2025 and december 31, 2024, respectively
---2,000
Total liabilities and stockholders' equity
37,977 50,183 39,613 47,689
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$15,167K Marketable securities$14,576K Prepaid expenses andother current assets$1,998K Total current assets$31,741K Property and equipment,net$2,990K Right of use assets$2,399K Other assets$847K Total assets$37,977K Total liabilities andstockholders' equity$37,977K Total stockholders'equity$26,716K Total liabilities$11,261K Accumulated deficit-$445,776K Accumulated othercomprehensive (loss) income-$2K Additional paid-in capital$472,490K Total currentliabilities$6,891K Lease liabilities,long term$3,879K Other long-termliabilities$491K Common stock, par valueof 0.001 per share...$4K Accrued liabilities andother liabilities$3,821K Accounts payable$3,070K

NextCure, Inc. (NXTC)

NextCure, Inc. (NXTC)